A

Arrowhead Pharmaceuticals
D

ARWR

12.680
USD
0.48
(3.89%)
مغلق
حجم التداول
52,279
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
1,741,184,290
أصول ذات صلة
ALNY
ALNY
11.07
(4.32%)
267.03 USD
C
CRSP
1.090
(3.29%)
34.200 USD
E
EDIT
0.05500
(4.85%)
1.19000 USD
I
IONS
1.455
(5.34%)
28.715 USD
MRNA
MRNA
0.580
(2.14%)
27.720 USD
N
NTLA
0.65000
(9.77%)
7.30500 USD
REGN
REGN
8.56
(1.39%)
625.24 USD
S
SGMO
0.08580
(15.15%)
0.65200 USD
S
SRPT
0.610
(0.99%)
62.490 USD
VRTX
VRTX
-1.36
(-0.28%)
483.38 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.